Formula I Compounds Modulating Histone Methylating Enzymes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective modulation of histone methyl modifying enzymes, which are crucial for regulating diverse biological processes such as gene expression, cell proliferation, and embryonic development.
Innovation Solution
Development of compounds with a specific formula that stimulate the activity of histone methyl modifying enzymes, including histone methylases and demethylases, to modulate their activity effectively.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If no modulation compounds are used, then methyl modifying enzyme activity remains uncontrolled, but disease treatment is ineffective
Solution Approach 1:
The patent introduces compounds of formula I as intermediary substances that mediate between the researcher/clinician and the methyl modifying enzymes. These compounds selectively modulate enzyme activity (stimulating demethylases while inhibiting methylases) to treat diseases, effectively acting as a controllable bridge that enables reliable disease treatment through enzyme modulation.
2Reliability
If methyl modifying enzyme activity is stimulated, then gene expression regulation improves, but selective modulation becomes difficult
Solution Approach 1:
The compounds of formula I exhibit local quality by displaying different modulatory effects on different enzyme types. Specifically, they stimulate histone demethylase activity while simultaneously inhibiting histone methylase activity, allowing selective and differential regulation of opposing enzymatic pathways to achieve precise gene expression control.
Solution Approach 2:
The invention utilizes parameter changes by modifying chemical structures (varying R1, R2, Z, X1-X5, L1, n parameters in formula I) to tune the compounds' selectivity and potency. This allows optimization of the stimulation/inhibition ratio between demethylases and methylases, enabling adaptable selective modulation for different disease indications.
3Stability of the object's composition
If histone methylation is increased, then chromatin structure changes, but transcription activation becomes uncontrolled
Solution Approach 1:
The patent applies inversion by simultaneously targeting both directions of histone methylation: it stimulates demethylases to remove methyl groups (decreasing methylation for activation) while inhibiting methylases that add methyl groups (preventing repression). This dual-action approach provides balanced control over chromatin structure and transcription activation, avoiding uncontrolled effects.
Data Source
AI summary
Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.